Education
About Us
Working with TipRanks
Follow Us
PharmX Technologies Limited (AU:PHX)
ASX:PHX
PHX Stock Chart & Stats
AU$0.16
<AU$0.01(5.00%)
At close: 4:00 PM EST
AU$0.16
<AU$0.01(5.00%)
Day’s Range― - ―
52-Week RangeAU$0.07 - AU$0.20
Previous CloseN/A
Volume723.89K
Average Volume (3M)1.01M
Market Cap
AU$92.92M
Enterprise ValueAU$52.38M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.22
Next Earnings
Feb 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding599,506,800
10 Day Avg. Volume421,582
30 Day Avg. Volume1,005,256
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PharmX Technologies News
PHX FAQ
What was PharmX Technologies Limited’s price range in the past 12 months?
PharmX Technologies Limited lowest share price was AU$0.07 and its highest was AU$0.20 in the past 12 months.
What is PharmX Technologies Limited’s market cap?
PharmX Technologies Limited’s market cap is AU$92.92M.
When is PharmX Technologies Limited’s upcoming earnings report date?
PharmX Technologies Limited’s upcoming earnings report date is Feb 24, 2026 which is in 87 days.
How were PharmX Technologies Limited’s earnings last quarter?
PharmX Technologies Limited released its earnings results on Aug 19, 2025. The company reported -AU$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.001.
Is PharmX Technologies Limited overvalued?
According to Wall Street analysts PharmX Technologies Limited’s price is currently Overvalued.
Does PharmX Technologies Limited pay dividends?
PharmX Technologies Limited does not currently pay dividends.
What is PharmX Technologies Limited’s EPS estimate?
PharmX Technologies Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PharmX Technologies Limited have?
PharmX Technologies Limited has 599,506,800 shares outstanding.
What happened to PharmX Technologies Limited’s price movement after its last earnings report?
PharmX Technologies Limited reported an EPS of -AU$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of PharmX Technologies Limited?
Currently, no hedge funds are holding shares in AU:PHX
PharmX Technologies Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
177.77%
12-Months-Change
Fundamentals
Return on Equity
-1.66%
Trailing 12-Months
Asset Growth
-36.95%
Trailing 12-Months
Company Description
PharmX Technologies Limited
Corum Group Ltd is an Australia-based software and technology company. it has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business. the company discontinued the e-commerce business in 2022.
Technical Analysis
Ava Risk Group Ltd.
―
1st Group Ltd.
―
Wiseway Group Ltd.
―
Li-S Energy Ltd
―
Aquirian Limited
―